These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
684 related articles for article (PubMed ID: 29147032)
1. Emptying the stores: lysosomal diseases and therapeutic strategies. Platt FM Nat Rev Drug Discov; 2018 Feb; 17(2):133-150. PubMed ID: 29147032 [TBL] [Abstract][Full Text] [Related]
2. Enzyme Replacement Therapy: A Review and Its Role in Treating Lysosomal Storage Diseases. Li M Pediatr Ann; 2018 May; 47(5):e191-e197. PubMed ID: 29750286 [TBL] [Abstract][Full Text] [Related]
3. Glyco-engineering strategies for the development of therapeutic enzymes with improved efficacy for the treatment of lysosomal storage diseases. Oh DB BMB Rep; 2015 Aug; 48(8):438-44. PubMed ID: 25999178 [TBL] [Abstract][Full Text] [Related]
6. Ten plus one challenges in diseases of the lysosomal system. Grabowski GA; Whitley C Mol Genet Metab; 2017; 120(1-2):38-46. PubMed ID: 27923545 [TBL] [Abstract][Full Text] [Related]
7. Enzyme enhancement therapeutics for lysosomal storage diseases: Current status and perspective. Thomas R; Kermode AR Mol Genet Metab; 2019 Feb; 126(2):83-97. PubMed ID: 30528228 [TBL] [Abstract][Full Text] [Related]
8. Stem Cell Applications in Lysosomal Storage Disorders: Progress and Ongoing Challenges. Köse S; Aerts-Kaya F; Uçkan Çetinkaya D; Korkusuz P Adv Exp Med Biol; 2021; 1347():135-162. PubMed ID: 33977438 [TBL] [Abstract][Full Text] [Related]
9. Personalized Pharmacoperones for Lysosomal Storage Disorder: Approach for Next-Generation Treatment. Haneef SA; Doss CG Adv Protein Chem Struct Biol; 2016; 102():225-65. PubMed ID: 26827607 [TBL] [Abstract][Full Text] [Related]
10. Treatment of lysosomal storage diseases: recent patents and future strategies. Ortolano S; Viéitez I; Navarro C; Spuch C Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):9-25. PubMed ID: 24433521 [TBL] [Abstract][Full Text] [Related]
11. Treating lysosomal storage disorders: What have we learnt? Lachmann RH J Inherit Metab Dis; 2020 Jan; 43(1):125-132. PubMed ID: 31140601 [TBL] [Abstract][Full Text] [Related]
12. Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics. Parenti G EMBO Mol Med; 2009 Aug; 1(5):268-79. PubMed ID: 20049730 [TBL] [Abstract][Full Text] [Related]
13. Treatment for LSDs: no longer just enzyme replacement therapy for Gaucher disease. Foreword. Cohen IJ; Baris H; Mistry PK Pediatr Endocrinol Rev; 2013 Nov; 11 Suppl 1():58. PubMed ID: 24380122 [No Abstract] [Full Text] [Related]